549 related articles for article (PubMed ID: 9765203)
1. Premature senescence involving p53 and p16 is activated in response to constitutive MEK/MAPK mitogenic signaling.
Lin AW; Barradas M; Stone JC; van Aelst L; Serrano M; Lowe SW
Genes Dev; 1998 Oct; 12(19):3008-19. PubMed ID: 9765203
[TBL] [Abstract][Full Text] [Related]
2. Sequential activation of the MEK-extracellular signal-regulated kinase and MKK3/6-p38 mitogen-activated protein kinase pathways mediates oncogenic ras-induced premature senescence.
Wang W; Chen JX; Liao R; Deng Q; Zhou JJ; Huang S; Sun P
Mol Cell Biol; 2002 May; 22(10):3389-403. PubMed ID: 11971971
[TBL] [Abstract][Full Text] [Related]
3. Senescence of human fibroblasts induced by oncogenic Raf.
Zhu J; Woods D; McMahon M; Bishop JM
Genes Dev; 1998 Oct; 12(19):2997-3007. PubMed ID: 9765202
[TBL] [Abstract][Full Text] [Related]
4. Oncogenic ras and p53 cooperate to induce cellular senescence.
Ferbeyre G; de Stanchina E; Lin AW; Querido E; McCurrach ME; Hannon GJ; Lowe SW
Mol Cell Biol; 2002 May; 22(10):3497-508. PubMed ID: 11971980
[TBL] [Abstract][Full Text] [Related]
5. E2FBP1 antagonizes the p16(INK4A)-Rb tumor suppressor machinery for growth suppression and cellular senescence by regulating promyelocytic leukemia protein stability.
Fukuyo Y; Takahashi A; Hara E; Horikoshi N; Pandita TK; Nakajima T
Int J Oral Sci; 2011 Oct; 3(4):200-8. PubMed ID: 22010578
[TBL] [Abstract][Full Text] [Related]
6. Depletion of ERK2 but not ERK1 abrogates oncogenic Ras-induced senescence.
Shin J; Yang J; Lee JC; Baek KH
Cell Signal; 2013 Dec; 25(12):2540-7. PubMed ID: 23993963
[TBL] [Abstract][Full Text] [Related]
7. Synergy between the Mos/mitogen-activated protein kinase pathway and loss of p53 function in transformation and chromosome instability.
Fukasawa K; Vande Woude GF
Mol Cell Biol; 1997 Jan; 17(1):506-18. PubMed ID: 8972231
[TBL] [Abstract][Full Text] [Related]
8. High intensity ras signaling induces premature senescence by activating p38 pathway in primary human fibroblasts.
Deng Q; Liao R; Wu BL; Sun P
J Biol Chem; 2004 Jan; 279(2):1050-9. PubMed ID: 14593117
[TBL] [Abstract][Full Text] [Related]
9. RasV12-mediated down-regulation of CCAAT/enhancer binding protein beta in immortalized fibroblasts requires loss of p19Arf and facilitates bypass of oncogene-induced senescence.
Sebastian T; Johnson PF
Cancer Res; 2009 Mar; 69(6):2588-98. PubMed ID: 19276382
[TBL] [Abstract][Full Text] [Related]
10. Replicative senescence of human fibroblasts: the role of Ras-dependent signaling and oxidative stress.
Hütter E; Unterluggauer H; Uberall F; Schramek H; Jansen-Dürr P
Exp Gerontol; 2002; 37(10-11):1165-74. PubMed ID: 12470828
[TBL] [Abstract][Full Text] [Related]
11. Differential contribution of the ERK and JNK mitogen-activated protein kinase cascades to Ras transformation of HT1080 fibrosarcoma and DLD-1 colon carcinoma cells.
Plattner R; Gupta S; Khosravi-Far R; Sato KY; Perucho M; Der CJ; Stanbridge EJ
Oncogene; 1999 Mar; 18(10):1807-17. PubMed ID: 10086335
[TBL] [Abstract][Full Text] [Related]
12. Comparative effects of insulin on the activation of the Raf/Mos-dependent MAP kinase cascade in vitellogenic versus postvitellogenic Xenopus oocytes.
Chesnel F; Bonnec G; Tardivel A; Boujard D
Dev Biol; 1997 Aug; 188(1):122-33. PubMed ID: 9245517
[TBL] [Abstract][Full Text] [Related]
13. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a.
Serrano M; Lin AW; McCurrach ME; Beach D; Lowe SW
Cell; 1997 Mar; 88(5):593-602. PubMed ID: 9054499
[TBL] [Abstract][Full Text] [Related]
14. Loss of oncogenic H-ras-induced cell cycle arrest and p38 mitogen-activated protein kinase activation by disruption of Gadd45a.
Bulavin DV; Kovalsky O; Hollander MC; Fornace AJ
Mol Cell Biol; 2003 Jun; 23(11):3859-71. PubMed ID: 12748288
[TBL] [Abstract][Full Text] [Related]
15. Dual role of MEK/ERK signaling in senescence and transformation of intestinal epithelial cells.
Boucher MJ; Jean D; Vézina A; Rivard N
Am J Physiol Gastrointest Liver Physiol; 2004 May; 286(5):G736-46. PubMed ID: 14701721
[TBL] [Abstract][Full Text] [Related]
16. The molecular scaffold kinase suppressor of Ras 1 is a modifier of RasV12-induced and replicative senescence.
Kortum RL; Johnson HJ; Costanzo DL; Volle DJ; Razidlo GL; Fusello AM; Shaw AS; Lewis RE
Mol Cell Biol; 2006 Mar; 26(6):2202-14. PubMed ID: 16507997
[TBL] [Abstract][Full Text] [Related]
17. Regulation of BCR- and PKC/Ca(2+)-mediated activation of the Raf1/MEK/MAPK pathway by protein-tyrosine kinase and -tyrosine phosphatase activities.
Kawauchi K; Lazarus AH; Sanghera JS; Man GL; Pelech SL; Delovitch TL
Mol Immunol; 1996 Feb; 33(3):287-96. PubMed ID: 8649450
[TBL] [Abstract][Full Text] [Related]
18. Cell-cycle-dependent activation of mitogen-activated protein kinase kinase (MEK-1/2) in myeloid leukemia cell lines and induction of growth inhibition and apoptosis by inhibitors of RAS signaling.
Morgan MA; Dolp O; Reuter CW
Blood; 2001 Mar; 97(6):1823-34. PubMed ID: 11238126
[TBL] [Abstract][Full Text] [Related]
19. The p38 pathway provides negative feedback for Ras proliferative signaling.
Chen G; Hitomi M; Han J; Stacey DW
J Biol Chem; 2000 Dec; 275(50):38973-80. PubMed ID: 10978313
[TBL] [Abstract][Full Text] [Related]
20. Age-related reductions in the activation of mitogen-activated protein kinases p44mapk/ERK1 and p42mapk/ERK2 in human T cells stimulated via ligation of the T cell receptor complex.
Whisler RL; Newhouse YG; Bagenstose SE
Cell Immunol; 1996 Mar; 168(2):201-10. PubMed ID: 8640866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
